Evans Mark G, Thomas Logan W, Nakasaki Manando, Charifa Ahmad, Sisk Anthony, Liu Sandy, Kuklinski Lawrence F, Shuch Brian, Quintero-Rivera Fabiola
Caris Life Sciences, Phoenix, Arizona, USA.
West Dermatology, Santa Maria, California, USA.
Cancer Genet. 2025 Apr;292-293:65-68. doi: 10.1016/j.cancergen.2025.01.007. Epub 2025 Jan 31.
Birt-Hogg-Dubé syndrome (BHDS) is characterized by autosomal dominant alterations in the Folliculin (FLCN) gene, resulting in cutaneous, pulmonary, and renal abnormalities. In particular, affected individuals are susceptible to the development of renal cell carcinoma (RCC), which most frequently present as chromophobe tumors or hybrid cancers with features of oncocytoma and chromophobe RCC. Type 1 and type 2 papillary neoplasms have rarely been described in the setting of BHDS, and we present two additional cases. Utilizing next-generation sequencing, the patients were found to harbor germline FLCN variants that are not well-documented in the medical literature. While RCCs associated with BHDS are thought to portend a better prognosis compared to their non-syndromic counterparts, the patients described here experienced variable clinical outcomes-one developed locally aggressive disease, distant metastases, and quickly succumbed to his disease.
Birt-Hogg-Dubé综合征(BHDS)的特征是卵泡抑素(FLCN)基因的常染色体显性改变,导致皮肤、肺部和肾脏异常。特别是,受影响的个体易患肾细胞癌(RCC),其最常表现为嫌色细胞瘤或具有嗜酸细胞瘤和嫌色性肾细胞癌特征的混合癌。1型和2型乳头状肿瘤在BHDS背景下很少被描述,我们在此报告另外两例病例。通过下一代测序,发现这两名患者携带医学文献中记载不足的种系FLCN变异。虽然与BHDS相关的肾细胞癌被认为比非综合征性肾细胞癌预后更好,但此处描述的患者临床结局各异——其中一名患者发生了局部侵袭性疾病、远处转移,并很快死于该疾病。